Skip to main content
USNA logo

USANA Health Sciences, Inc. (USNA) Stock Price & Analysis

USANA Health Sciences, Inc. (USNA) — MoonshotScore 73/100 (Strong band), calculated Nov 18, 2026. Price $12.94 (-1.67%), as of the Nov 20, 2026 trading session; market cap $239M.

Educational signal · not a buy or sell recommendation · How to read this

$12.94 −$0.22 (-1.67%) Market Cap $239M

USANA Health Sciences, Inc. · USNA · NYSE

USANA Health Sciences, Inc. develops, manufactures, and sells nutritional and personal care products. The company operates primarily through direct sales in the Asia Pacific, the Americas, and Europe.

Price as of Nov 20, 2026

Key Statistics

73 of 100

MoonshotScore v2 · USANA Health Sciences (USNA)

Strong
Business Quality Solid (65)
Financial Safety Sound (75)
Valuation Cheap (97)
Growth Durability Fading (21)
Momentum Slipping (38)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

A strong balance sheet, at a dirt-cheap price, but stalling growth. Business Quality: Solid; Financial Safety: Sound; Valuation: Cheap; Growth Durability: Fading; Momentum: Slipping.

  • EPS beat 0 of the last 4 reports
  • Altman Z 3.56 · Piotroski F 4
  • ROE -5.1% · ROA 3.4% · current ratio 2.59

Holding back: soft growth

Helping: balance-sheet strength, an attractive price

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for USNA (58 recorded, newest six shown)
RecordedScoreBand
73Strong
74Strong
74Strong
73Strong
73Strong
73Strong

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$12.94
Change on the day-1.67%
52-week range$12.53 – $23.59
Market capitalisation$239M—
Price / earnings (trailing)45.04
Shares traded on the day158.8K

Price & events

Other perspectives

Council score for USANA Health Sciences (USNA): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Moderate
Financial Safety Moderate
Valuation Strong
Growth Durability Weak
Momentum Weak

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Neutral read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Neutral read

Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Undervalued
Profit Margin Weak
ROE Negative
Gross Margin Strong

Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 17, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.

Readings on this page are from Nov 21, 2026, except a card that shows its own read date.

1 · What is it?

What is USANA Health Sciences (USNA), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. USANA Health Sciences, Inc. (USNA) is listed on NYSE. It employs 1,570 people and is led by Kevin G. Guest. The market values it at $239M.

2 · Latest results

What do the latest results show for USANA Health Sciences (USNA)?

Short answer · as of

Against analyst estimates the company has EPS beat 0 of the last 4 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Sep 2025$214M-$7M-$0.36 (diluted)
Dec 2025$226M-$2M-$0.10 (diluted)
Mar 2026$250M$7M$0.38 (diluted)
Jun 2026$223M-$21M-$1.16 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for USANA Health Sciences (USNA)?

Short answer

The MoonshotScore pillars rate balance-sheet strength, an attractive price as strengths. What is holding it back is soft growth. The distress and quality screens read Altman Z 3.56 · Piotroski F 4. Trailing ratios: ROE -5.1% · ROA 3.4% · current ratio 2.59.

Data-derived red flags

  • Negative return on equity (-5.1%) — the business is not currently generating profit on shareholder capital.
  • Inconsistent delivery — missed Wall Street EPS estimates in 2 of the last 4 reported quarters.
4 · What to check next?

What should you watch next at USANA Health Sciences (USNA)?

Short answer · as of

Analyst estimates on file carry FY2027 revenue $899.08M · EPS 0.55 · 1 analysts.

What the records here don't tell us

  • The next earnings date is not yet scheduled in the calendar we read.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does USANA Health Sciences compare with its peers?

Short answer

USANA Health Sciences's score ranks 2nd of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Herbalife Nutrition Ltd. (HLF) Named competitor$15.53 Nov 20, 2026$1.63B92 5-pillar Nov 18, 2026
USANA Health Sciences (USNA) — this page$12.94$239M73
Mama's Creations, Inc. (MAMA) Same industry, near in market value$11.08 Nov 20, 2026$522M71 5-pillar Nov 18, 2026
John B. Sanfilippo & Son, Inc. (JBSS) Same industry, near in market value$60.77 Nov 19, 2026$711M67 5-pillar Nov 18, 2026
The Simply Good Foods Company (SMPL) Same industry, near in market value$11.91 Nov 20, 2026$1.03B65 5-pillar Nov 18, 2026
FitLife Brands, Inc. (FTLF) Same industry, near in market value$6.20 Nov 20, 2026$58.2M63 5-pillar Nov 18, 2026
B&G Foods, Inc. (BGS) Same industry, near in market value$3.63 Nov 20, 2026$295M43 5-pillar Nov 18, 2026
Nature's Sunshine Products, Inc. (NATR) Same industry, near in market value$10.18 Nov 20, 2026$176M43 5-pillar Nov 18, 2026
Lifeway Foods, Inc. (LWAY) Same industry, near in market value$19.17 Nov 20, 2026$290M39 5-pillar Nov 18, 2026
Nu Skin Enterprises, Inc. (NUS) Named competitor$3.80 Nov 20, 2026$185M35 5-pillar Nov 18, 2026
BRC Inc. (BRCC) Same industry, near in market value$7.21 Nov 20, 2026$181M34 5-pillar Nov 18, 2026
Once Upon A Farm Pbc (OFRM) Same industry, near in market value$12.17 Nov 20, 2026$514M33 5-pillar Nov 18, 2026
Westrock Coffee Company, LLC (WEST) Same industry, near in market value$7.22 Nov 20, 2026$723M28 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Analyst targets & estimates

What analysts have on file

Revenue estimate
$899.08M
EPS estimate
$0.55

Measured against a quoted price of $12.94 (as of Nov 20, 2026).

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Oct 22, 2026

Transactions
47
Identified insiders
12
Purchases
0
Sales
7
Other transactions
40

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held USNA in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported USNA in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about USANA Health Sciences (USNA)?

Read these with our analysis →

What Investors Ask About USANA Health Sciences (USNA)

These answers are editorial: 1 of these 9 answers is drawn from the USNA research dossier (written May 9, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for USNA?

USNA carries the MoonshotScore stated above — the Strong band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. USANA Health Sciences, Inc. develops, manufactures, and sells nutritional and personal care products.

Is USNA a good stock to buy?

Stock Expert AI does not rate USNA buy, sell or hold. USANA Health Sciences, Inc. carries a MoonshotScore, in the Strong band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the USNA stock price today?

The last price recorded for USANA Health Sciences, Inc. (USNA), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What does USANA Health Sciences, Inc. do?

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products through a direct sales model. The company's product portfolio includes vitamin and mineral supplements, targeted supplements for specific health needs, meal replacement shakes, snack bars, and skin care products.

What are the key factors to evaluate for USNA?

USANA Health Sciences, Inc. (USNA) holds a MoonshotScore in the high range. To weigh it, start with the trailing P/E under Price & valuation on this page. These partnerships can be established within the next year and contribute to long-term growth. Not financial advice.

How frequently does USNA data refresh on this page?

USNA's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven USNA's recent stock price performance?

USANA Health Sciences, Inc. (USNA) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong brand reputation for high-quality products. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider USNA overvalued or undervalued right now?

The trailing P/E of USANA Health Sciences, Inc. (USNA) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of USNA?

Fractional-share availability for USANA Health Sciences, Inc. (USNA) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 9, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 17 figures on this page — 7 from Financial Modeling Prep (FMP), 9 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.